Näytös/Näyttely25 award-winning works on display in the Bio Rex lobby
The partnership between Aalto University and Föreningen Konstsamfundet is deepening. Konstsamfundet has previously supported Aalto University's fashion and textiles by awarding its own prize at the annual Näytös/Näyttely event, but now the collaboration is being deepened in two stages.
In the first stage in 2025, the awarded Näytös/Näyttely works were showcased in a small fashion show at Bio Rex in Lasipalatsi, and all winning and honourable mention works will be on display in the Bio Rex lobby from 10 to 15 June.
The exhibition is open Wed-Fri from 11-18 and Sat-Sun from 11-17, free admission.
Address: Bio Rex, Mannerheimintie 22-24.
At the Bio Rex event, Aalto and Konstsamfundet announced that their collaboration will enter into its second phase next year. This means that the Näytös/Näyttely26 event will be held in the urban cultural hub of the Lasipalatsi block.
'Konstsamfundet wants to be an enabler of creative young people and new ideas. Collaboration with Aalto University is natural for us, and we are now planning to expand it in the coming years,' says Stefan Björkman, CEO of Föreningen Konstsamfundet.
'It is extremely important that we have good partners who share our values,' says Ilona Hyötyläinen, head of the Bachelor’s programme in fashion at Aalto University.
Explore the Näytös/Näyttely25 winning concepts here.
More information:
Ilona Hyötyläinen, head of the Näytös/Näyttely event and head of the Bachelor’s programme in fashion at Aalto University
ilona.hyotylainen@aalto.fi
Read more news
What is quantum tech?
Many of today’s devices would not exist without quantum technology, but the most exciting applications are still on the horizon
Is quantum the next AI? Behind the quantum hype
Doctoral researcher Christa Schauman explains how Finland and Europe are faring in a race everyone wants to join – despite its uncertainties.
Health x technology: Magnetic stimulation activates neurons to target depression
Brain stimulation has helped depression patients for years, yet only a small minority can access the therapy. Researchers are now making it easier, faster, and more personalised.